Sort
53,477 grants matching “addiction”
CTN CLINICAL COORDINATING CENTER TASK ORDER 8. POP 2/24/23 â 2/23/24
$842,918Eve Jelstrom · The Emmes Company, Llc · N01 · FY2024 · DA
Molecular underpinnings of the developmental Effects of Cannabis
$842,905Yasmin L Hurd · Icahn School Of Medicine At Mount Sinai · R01 · FY2023 · DA
Phase II clinical evaluation of Omnitram in neuropathic pain
$842,819Stuart J Kahn · Syntrix Biosystems, Inc. · R44 · FY2016 · DA
Electrophysiological and electrochemical studies of addictive drugs
$842,799Eugene A Kiyatkin · National Institute On Drug Abuse · ZIA · FY2023 · DA
Inhibitors of Tyrosine Kinase-Dependent Signaling as Anti-Cancer Agents
$842,594Terrence Burke · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
Increasing the Efficiency of RE-JOIN Through Data Sharing and Integration
$842,580Brendan Hl Lee · Baylor College Of Medicine · UC2 · FY2025 · AR
Peer-Delivered Behavioral Activation Intervention to Improve Adherence to MAT Among Low-Income, Minority Individuals With OUD
$842,519Jessica F Magidson · Univ Of Maryland, College Park · R33 · FY2024 · DA
Prevention of Neonatal Abstinence Syndrome
$842,368Gary A Peltz · Stanford University · R01 · FY2012 · HD
Neuroimaging of Brain Circuits and Neurogenetic Mechanisms in Normal Cognition
$841,975Karen Faith Berman · National Institute Of Mental Health · ZIA · FY2009 · MH
Mu Opioid Receptor in Addiction
$841,783Wade H Berrettini · University Of Pennsylvania · P20 · FY2010 · DA
Repressive Histone and DNA Methylation in Stimulant and Opiate Addiction
$841,753Eric J Nestler · Icahn School Of Medicine At Mount Sinai · P01 · FY2017 · DA
mHealth to Enhance & Sustain Drug Use Reduction of the QUIT BI in Primary Care
$841,444Lillian Gelberg · University Of California Los Angeles · R01 · FY2023 · DA
Increasing Peer Support for OUD Recovery during COVID-19 through Digital Health: A National Randomized Controlled Trial
$841,369Megan Larin Ranney · Brown University · R01 · FY2021 · DA
Integration of Virtual Reality Mindfulness Application Within a Mobile-Based Recovery Platform to Support Rehab and Post-Rehab Engagement
$840,913Peter Alan Wilkinson · Sober Grid, Inc. · R44 · FY2021 · DA
Early Prevention of Substance Use Initiation in Foster Care
$840,777Lourdes Oriana Linares · Icahn School Of Medicine At Mount Sinai · R01 · FY2009 · DA
ProGel Technology for Better Management of Osteoarthritis Pain
$840,440Steven Reyburn Goldring · Ensign Pharmaceutical, Inc · R44 · FY2022 · DA
ProGel Technology for Better Management of Osteoarthritis Pain
$840,440Steven Reyburn Goldring · Ensign Pharmaceutical, Inc · R44 · FY2021 · DA
Novel non-narcotic analgesic for acute and chronic pain
$840,427Nicolas Guillermo Bazan · South Rampart Pharma, Llc · R42 · FY2021 · NS
Novel non-narcotic analgesic for acute and chronic pain
$840,427Nicolas Guillermo Bazan · South Rampart Pharma, Llc · R42 · FY2022 · NS
Harnessing Knowledge of Gene Function in Brain Tissue for Discovering Biology Underlying Heroin Addiction
$840,187Eric O Johnson · Research Triangle Institute · R01 · FY2018 · DA
Genetics of novelty seeking and propensity for drug abuse in outbred rats
$840,034Huda Akil · University Of Michigan At Ann Arbor · U01 · FY2025 · DA
Synaptic mechanisms underlying reward seeking and compulsive drug use
$839,900Veronica A Alvarez · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2023 · AA
The Comparative Effectiveness and Safety of Pharmacotherapies for the Treatment of Opioid Use Disorder in Pregnancy
$839,898Krista F Huybrechts · Brigham And Women'S Hospital · R01 · FY2024 · DA
Mapping brain-wide opioid actions by profiling neuronal activities and in vivo cellular target engagement
$839,850Li Ye · Scripps Research Institute, The · R01 · FY2023 · DA
Nociceptin, NOPR and Sleep/Wake Control
$839,815Thomas S Kilduff · Sri International · R01 · FY2025 · NS